Product
Istaroxime
Aliases
PST2744
3 clinical trials
2 indications
Indication
Cardiogenic ShockIndication
acute decompensated heart failureClinical trial
A Multicenter, Randomized, Placebo-Controlled, Parallel Group Trial on the Safety and Efficacy of Istaroxime for Cardiogenic Shock SCAI Stage CStatus: Not yet recruiting, Estimated PCD: 2024-07-01
Clinical trial
The Clinical Study of the Safety and Efficacy of Istaroxime in Treatment of Acute Decompensated Heart Failure - A Multicenter, Randomized, Double-blind, Placebo Controlled, Parallel Group Clinical StudyStatus: Completed, Estimated PCD: 2018-08-14
Clinical trial
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study on the Safety and Efficacy of Istaroxime for Pre-Cardiogenic Shock (SEISMiC)Status: Active (not recruiting), Estimated PCD: 2024-03-30